mardi 10 janvier 2017

Onco Actu du 10 janvier 2017

1.1 Biologie - Gènes

Researchers reveal how cancer cells cope with genetic chaos [The Francis Crick Institute]

3.1 Tabac

Whitewashing a black box warning: The Chantix story that didn’t get told [HealthNewsReview]

Smoking costs $1 trillion, soon to kill 8 million a year: WHO/NCI study [Reuters]

4.1 Dép., diag. & prono. - Prostate

Newly discovered genetic fingerprint for prostate cancer promises to personalize treatment [FierceBiotech]

4.12 Biopsies liquides

Why I'm Wary Of Grail And Its Plan To Develop A Cancer Detection Blood Test [Forbes]

4.2 Dép., diag. & prono. - Génome

Illumina Promises To Sequence Human Genome For $100 -- But Not Quite Yet [Forbes]

Illumina says it can deliver a $100 genome — soon [STAT]

4.9 Dép., diag. & prono. - Sein

The Case for Annual Mammograms Is More Complicated Than Ever [Time]

In Obamacare era, older women get more cancer screenings [Reuters]

Danish Study Raises More Questions About Mammograms' Message [NPR]

Mammograms tied to overdiagnosis of breast cancer [Reuters]

5. Traitements

Mayo Clinic researchers identify new potential treatment for cancer metastasis [Mayo Clinic]

5.12.1 Immunothérapies - partenariats

Amgen and Immatics enter $1bn immuno-oncology partnership [Pharmafile]

AbbVie unveils clutch of I-O, genomics research pacts [FierceBiotech]

Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to Develop and Commercialize Axicabtagene Ciloleucel (KTE-C19) in Japan [Kite]

Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab) [Merck]

Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M-plus deal [EndPoints]

Kite Pharma partners with Japan's Daiichi for cancer therapy [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

Takeda to Acquire ARIAD Pharmaceuticals, Inc. [Takeda]

'Staggering' Price Hikes Resulted In $5 Billion Payday For Ariad Pharma Investors [Forbes]

Takeda grabs Ariad, expands oncology portfolio in $5.2B buyout [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Multi-stakeholder paediatric oncology strategy workshop (cancers with ALK aberrations) [EMA]

Drug Approval Timeline Same as 20 Years Ago [The Scientist]

5.4 Traitements - Economie

Drugmakers question the future of drug prices under Trump [Washington Post]

6. Lutte contre les cancers

Pfizer contest dares tech types to improve lives of metastatic breast cancer patients [FiercePharma]

Peter Nowell, Co-Discoverer of the Philadelphia Chromosome, Dies [The Scientist]

6.10 Politiques

Brexit vote drives UK academics to think about leaving [Nature]

6.10.1 Politiques (USA)

Biden vows to push pharmaceutical companies to ‘ensure patients can afford treatments’ [STAT]

6.4 Médico-éco

MD Anderson lays off 900 staff members [The Cancer Letter]

6.7 DMP, Big Data & applis

HARMONY; a € 40 million project for better care of patients with hematologic malignancies [EHA]

Doug Lowy on the moonshot, NCI’s invigorated agenda [The Cancer Letter]

6.7.1 Bioinformatique

IBM, Illumina deploy Watson for Genomics in cancer research [FierceBiotech]

Illumina Adds IBM Watson To DNA Test For Cancer Patients [Forbes]